Zhejiang Nhu Co Ltd (SZSE:002001) Share Price

Company Profile

Business description
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives, and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer, and Anti-bacterial, with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3, and coenzyme Q10, and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.
Contact
No.418 Xinchang Dadao West Road
Xinchang County, Qixing Sub-district
Zhejiang Province
Shaoxing312500
CHN
T: +86 57586127777
https://www.cnhu.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
11,369

Recommended

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Shaun Ler | 30 July 2025

With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.

Malik Ahmed Khan, CFA | 30 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,986.20	29.20	-0.32%
CAC 40	7,861.96	4.60	0.06%
DAX 40	24,262.22	44.85	0.19%
Dow JONES (US)	44,461.28	171.71	-0.38%
FTSE 100	9,136.94	0.62	0.01%
HKSE	24,982.87	194.06	-0.77%
NASDAQ	21,129.67	31.38	0.15%
Nikkei 225	40,942.74	288.04	0.71%
NZX 50 Index	12,854.51	1.46	-0.01%
S&P 500	6,362.90	7.96	-0.12%
S&P/ASX 200	8,730.80	25.60	-0.29%
SSE Composite Index	3,614.63	1.09	-0.03%